Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease

AIMS: To determine if serum levels of serum amyloid A (SAA) predict death and end-stage renal disease in a cohort of people with diabetic kidney disease. METHODS: In a longitudinal cohort study of 135 participants with type 2 diabetes and diabetic kidney disease, serum samples were assayed for SAA....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Diabetes Complications
Main Authors: Dieter, Brad P., McPherson, Sterling M., Afkarian, Maryam, de Boer, Ian H., Mehrotra, Rajnish, Short, Robert, Barbosa-Leiker, Celestina, Alicic, Radica Z., Meek, Rick L., Tuttle, Katherine R.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5435122/
https://ncbi.nlm.nih.gov/pubmed/27522272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jdiacomp.2016.07.018
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki